We are live on ! Find out more
RCMU

Rokos Capital Management (UK) Portfolio holdings

AUM $26.8B
1-Year Est. Return 90.85%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+90.85%
3 Year Est. Return
+227.35%
5 Year Est. Return
+202.98%
10 Year Est. Return
AUM
$5.01B
AUM Growth
-$1.69B
Cap. Flow
-$2.02B
Cap. Flow %
-40.25%
Top 10 Hldgs %
58.02%
Holding
182
New
70
Increased
8
Reduced
31
Closed
47

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$100M
2
BMY icon
Bristol-Myers Squibb
BMY
+$74.7M
3
MRK icon
Merck
MRK
+$73.1M
4
TSLA icon
Tesla
TSLA
+$66.1M
5
PCG icon
PG&E
PCG
+$54.1M

Sector Composition

Rank Sector Weight
1 Technology 7.83%
2 Healthcare 5.33%
3 Consumer Discretionary 5.28%
4 Communication Services 3%
5 Financials 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JOAN
101
DELISTED
JOANN, Inc. Common Stock
JOAN
$1.18M 0.02%
75,000
-175,000
-70% -$2.4M
LZ icon
102
LegalZoom.com
LZ
$1.01B
$1.12M 0.02%
+40,000
New +$1.51M
TASK icon
103
TaskUs
TASK
$715M
$1.04M 0.02%
+30,000
New +$948K
FTAAU
104
DELISTED
FTAC Athena Acquisition Corp. Unit
FTAAU
$931K 0.02%
92,300
COUR icon
105
Coursera
COUR
$1.63B
$820K 0.02%
20,000
-20,000
-50% -$860K
DOCN icon
106
DigitalOcean
DOCN
$13.1B
$795K 0.02%
15,000
-15,000
-50% -$648K
AGL icon
107
Agilon Health
AGL
$1.61B
$789K 0.02%
+800
New +$701K
VZIO
108
DELISTED
VIZIO Holding Corp.
VZIO
$673K 0.01%
25,000
-25,000
-50% -$587K
NAPA
109
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$649K 0.01%
30,000
-70,000
-70% -$1.36M
OCDX
110
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$641K 0.01%
30,000
-270,000
-90% -$5.49M
YOU icon
111
Clear Secure
YOU
$4.47B
$623K 0.01%
+15,000
New +$600K
DIBS icon
112
1stdibs.com
DIBS
$153M
$528K 0.01%
+20,000
New +$515K
XMTR icon
113
Xometry
XMTR
$4.97B
$440K 0.01%
+10,000
New +$874K
BZ icon
114
Kanzhun
BZ
$7.23B
$397K 0.01%
+10,000
New +$385K
ZY
115
DELISTED
Zymergen Inc. Common Stock
ZY
$397K 0.01%
+10,000
New +$395K
INTA icon
116
Intapp
INTA
$3.15B
$390K 0.01%
+15,000
New +$420K
XM
117
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$385K 0.01%
10,000
-90,000
-90% -$3.16M
OTLY
118
Oatly Group
OTLY
$503M
$367K 0.01%
+750
New +$373K
FLYW icon
119
Flywire
FLYW
$2.34B
$355K 0.01%
+10,000
New +$335K
HNST icon
120
The Honest Company
HNST
$577M
$329K 0.01%
+20,000
New +$335K
ZH
121
Zhihu
ZH
$270M
$305K 0.01%
3,750
-3,750
-50% -$215K
ACVA icon
122
ACV Auctions
ACVA
$1.27B
$250K 0.01%
10,000
-10,000
-50% -$291K
FIGS icon
123
FIGS
FIGS
$2.43B
$240K ﹤0.01%
+5,000
New +$187K
PRVA icon
124
Privia Health
PRVA
$2.68B
$222K ﹤0.01%
+5,000
New +$184K
EDR
125
DELISTED
Endeavor Group Holdings, Inc.
EDR
$203K ﹤0.01%
+7,500
New +$216K

Similar funds

Rokos Capital Management (UK)'s Q2 2021 Portfolio in Review

As of Q2 2021, Rokos Capital Management (UK) held 182 positions worth $5.01B, down 25% from $6.71B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Rokos Capital Management (UK) withdrew a net $2.02B in Q2 2021, closing 47 positions and reducing 31 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $294M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, down from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Rokos Capital Management (UK) opened a new position in Alibaba worth $102M.

  • Rokos Capital Management (UK)'s largest Q2 2021 buy was Alibaba: 450,000 shares worth $102M.
  • Rokos Capital Management (UK) added most to Tesla in Q2 2021, an estimated $66.1M increase.
  • Rokos Capital Management (UK)'s biggest Q2 2021 reduction was Amazon, cutting an estimated $456M.
  • Rokos Capital Management (UK) fully exited Alphabet (Google) Class C in Q2 2021, selling an estimated $294M.
  • Rokos Capital Management (UK)'s ten largest holdings make up 58% of its $5.01B portfolio in Q2 2021.
  • Rokos Capital Management (UK) opened 70 new positions and closed 47 in Q2 2021.
  • Rokos Capital Management (UK)'s portfolio value fell 25% quarter-over-quarter to $5.01B.

Based on Rokos Capital Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.